Related Experiment Videos
Structural organization of the human TOP2A and TOP2B genes
A J Lang1, S E Mirski, H J Cummings
1Department of Pharmacology and Toxicology, Queen's University, Kingston, Ont. K7L 3N6, Canada.
Gene
|October 31, 1998
Summary
This study details the genomic structures of human topoisomerase IIalpha (TOP2A) and topoisomerase IIbeta (TOP2B) genes. Understanding these structures aids in identifying mutations linked to cancer drug resistance.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Eukaryotic topoisomerase II is crucial for DNA replication, transcription, and chromosome segregation.
- Vertebrates possess two topoisomerase II isoforms: alpha (TOP2A) and beta (TOP2B).
- TOP2A and TOP2B are key targets for cancer therapeutics, with TOP2A mutations linked to drug resistance.
Purpose of the Study:
- To define the intron-exon structures of human TOP2A and TOP2B genes.
- To investigate the evolutionary relationship between TOP2A and TOP2B based on their genomic organization.
- To identify mutation hotspots in TOP2A associated with drug resistance.
Main Methods:
- Comparative analysis of TOP2A and TOP2B gene sequences.
- Determination of intron-exon boundaries and gene sizes.
- Amino acid sequence alignment to assess conservation.
Main Results:
- TOP2A spans approximately 30kb with 35 exons; TOP2B spans at least 49kb with 36 exons.
- Both genes exhibit conserved intron-exon organization, suggesting evolution by gene duplication.
- Drug resistance-associated TOP2A mutations cluster in specific exons (12, 13, 19-21, 34-35).
Conclusions:
- The genomic organization of TOP2A and TOP2B supports an evolutionary model of gene duplication.
- Detailed knowledge of TOP2A and TOP2B genomic structures is vital for diagnosing drug-resistant cancers.
- This research provides a foundation for targeted mutation detection in clinical oncology settings.